Record quarterly revenue and shipments were achieved, with backlog expanding over 50% year-over-year. Despite higher sales and improved financial services margins, net income and EPS declined due to increased costs and expenses. Regulatory progress and strong order momentum support a positive outlo…
Strong first half 2026 results driven by demand for advanced Seed and Crop Protection products, with net sales up 4% and operating EBITDA up 10% year-over-year. Full-year guidance was raised, and the planned separation remains on track for October 1, 2026.Original document: Corteva, Inc. [CTVA] SEC…
Earnings and operating performance met expectations, with reaffirmed 2026 EPS guidance of $5.25–$5.45. Major infrastructure investments and new data center projects are set to drive significant sales and economic growth, while dividend growth and strong credit ratings support long-term value.Origin…
Net sales grew 5% year-over-year in Q2 2026, with net income rising to $126 million, driven by strong segment performance and cost controls, despite ongoing macroeconomic and regulatory challenges. Special items and restructuring costs continued to impact results.Original document: Baxter Internati…
Revenue grew 44% year-over-year to $335.0 million in Q2 2026, driven by strong oncology and screening test volume growth, while net loss widened to $120.1 million due to increased R&D and commercial investments. Cash reserves remain robust at $1.2 billion, supporting ongoing expansion and innovatio…
Q1 FY27 saw a 6.7% organic revenue decline and a 5.0% adjusted EBIT margin, both in line with guidance. Free cash flow rose to $314M, and net debt was reduced. FY27 guidance anticipates continued revenue decline but improved margins and strong free cash flow.Original document: DXC Technology Compan…
Q2 2026 saw 10.6% revenue growth to $6.35B, with net earnings of $925.7M and strong performance in Americas and Asia Pacific. Gross margin declined due to inflation, but free cash flow nearly doubled. Recent acquisitions and continued share repurchases support growth and capital returns.Original do…
OLED provider Universal Display NASDAQ:OLED missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 11.4% year on year to $152.2 million. On the other hand, the company’s full-year revenue guidance of $650 million at the midpoint came in 0.8% above analysts’ estimates. Its GAAP p…
Pentixapharm Holding AG/ Total Voting Rights AnnouncementPentixapharm Holding AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution30.07.2026 / 22:46 CET/CESTTotal Voting Rights Announcement transmitted by EQS News - a ser…
Q2 2026 revenue rose 14.9% year-over-year to $390 million, with strong growth in both thrombectomy and embolization/access products, especially in the U.S. Net income declined due to higher taxes and operating expenses. The company announced a $14.5 billion merger with Boston Scientific, expected t…
LONDON and NEW YORK, July 30, 2026 /PRNewswire/ -- Bank of America today announced plans to acquire information security specialist MDSec Consulting Limited ("MDSec"). The transaction is expected to be completed during the fourth quarter of 2026 following the receipt of regulatory approvals.Headqua…
Second quarter 2026 saw a 14% year-over-year revenue increase to $1.66 billion and adjusted EBITDA rise to $120 million, with all segments showing growth. The company announced a merger with Olin Corporation and continued to benefit from cost optimization, despite ongoing raw material volatility.Or…
The company refinanced and expanded its credit facilities, securing a $35M term loan (up to $65M) and a $30M revolving line (up to $45M), both maturing in 2031, with updated covenants, cross-collateralization, and enhanced lender protections. Amendments to supply agreements and the equity plan were…
Net income declined year-over-year due to lower premiums and investment income, despite reduced losses and expenses. The company maintained strong liquidity, repurchased shares, and amended its credit facility, while continuing to focus on underwriting discipline and technology investments.Original…
Financial services company The Bancorp NASDAQ:TBBK fell short of the market’s revenue expectations in Q2 CY2026, with sales falling 9.8% year on year to $163.5 million. Its GAAP profit of $1.45 per share was 6.4% above analysts’ consensus estimates.The Bancorp (TBBK) Q2 CY2026 Highlights:“Our perfo…
Revenue grew 25% year-over-year in Q2 2026, with Adjusted EBITDA doubling and operating profit rising sharply. Backlog remains strong at $10.5 billion, supporting a positive outlook for double-digit revenue growth in 2026 and further gains in 2027.Original document: Aecon Group Inc. [ARE] Earnings…
Q2 2026 saw 10% sales growth and a return to profitability, with net income of $26.8M and adjusted EBITDA margin of 16.0%. All segments contributed to higher sales, while restructuring and transformation programs are expected to drive future cost savings. Geopolitical and supply chain risks remain…
Revenue grew 30% year-over-year in Q2 2026 to $492.9 million, driven by major partnerships and organic growth, but the company reported a net loss of $39.0 million due to higher expenses and significant non-recurring items. Adjusted EBITDA margin improved to 24%, and liquidity remains strong with…
Q3 2026 revenue declined 3% year-over-year to $305M, with net income at $28.6M and diluted EPS of $0.30. Licensing revenue fell, mainly in mobile and PC, while products/services also declined due to lower cinema product sales. The company increased its dividend and stock repurchase authorization, a…
Q2 2026 saw higher net income and EPS, but a slight decline in same-store NOI due to rising expenses. Guidance for full-year EPS and FFO was raised, supported by strong operating performance and strategic capital moves, including a major joint venture and expanded credit facility.Original document…
